Evidence map›Paper›PMID 41298656›Full record

ArticleScientific reports2025

Publisher Correction: Single-cell and bulk transcriptomics uncovers PRKD2-driven tumor stemness and progression in multiple myeloma.

Guihua Zhang, Shengya Cao, Chong Geng, Yueyue Sun, Jinge Xu, Chong Chen, Faan Miao, Huanxin Zhang, Yunxin Kong, Rongke Jiang and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Guihua Zhang *Suzhou Medical College of Soochow University, Suzhou, 215006, Jiangsu, China.
Shengya Cao *Clinical Laboratory, Xuzhou Cancer Hospital, Xuzhou Third People's Hospital, Xuzhou, 221000, Jiangsu, China.
Chong Geng *Department of Radiotherapy, Xuzhou Cancer Hospital, Xuzhou Third People's Hospital, Xuzhou, 221000, Jiangsu, China.
Yueyue SunDepartment of Hematology, Affiliated Hospital of Xuzhou Medical University, No.99, Huaihai West Road, Xuzhou, 221000, Jiangsu, China.
Jinge XuDepartment of Hematology, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China.
Chong ChenDepartment of Hematology, Affiliated Hospital of Xuzhou Medical University, No.99, Huaihai West Road, Xuzhou, 221000, Jiangsu, China.
Faan MiaoDepartment of Hematology, Affiliated Hospital of Xuzhou Medical University, No.99, Huaihai West Road, Xuzhou, 221000, Jiangsu, China.
Huanxin ZhangDepartment of Hematology, Affiliated Hospital of Xuzhou Medical University, No.99, Huaihai West Road, Xuzhou, 221000, Jiangsu, China.
Yunxin KongCancer Prevention Office, Xuzhou Cancer Hospital, Xuzhou Third People's Hospital, Xuzhou, 221000, Jiangsu, China.
Rongke JiangDepartment of Hematology, Xuzhou Cancer Hospital, Xuzhou Third People's Hospital, Xuzhou, 221000, Jiangsu, China.
Kaige LiuDepartment of Hematology, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China.
Jiaqian QiSuzhou Medical College of Soochow University, Suzhou, 215006, Jiangsu, China. qijq@suda.edu.cn.
Zhenyu LiDepartment of Hematology, Affiliated Hospital of Xuzhou Medical University, No.99, Huaihai West Road, Xuzhou, 221000, Jiangsu, China. lizhenyumd@163.com.
Hong LiuSuzhou Medical College of Soochow University, Suzhou, 215006, Jiangsu, China. hongliu63@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41298656
PMCPMC12658171

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.